uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit

uBriGene Biosciences (uBriGene) announced the submission of its Drug Master File for its innovative iPSC Reprogramming mRNA-LNP Kit. This comprehensive regulatory submission details the manufacturing and characterizations of the iPSC Reprogramming mRNA-LNP Kit.